Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.
作者信息
Kew M C, Berger E L, Koprowski H
出版信息
Br J Cancer. 1987 Jul;56(1):86-8. doi: 10.1038/bjc.1987.160.
Abstract
摘要
相似文献
1
Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.碳水化合物抗原19-9作为肝细胞癌的血清标志物：与甲胎蛋白的比较。
Br J Cancer. 1987 Jul;56(1):86-8. doi: 10.1038/bjc.1987.160.
2
Presence of a hepatoma-liver antigen in the sera of patients with primary hepatocellular carcinoma.
Singapore Med J. 1979 Jun;20(2):317-22.
3
4
[alpha 1-fetoprotein and Tennessee antigen in hepatocellular carcinomas and in metastatic liver cancer (author's transl)].肝细胞癌和转移性肝癌中的甲胎蛋白与田纳西抗原（作者译）
Wien Klin Wochenschr. 1982 Feb 19;94(4):102-5.
5
Nature and expression of tumour antigens associated with experimental animal and human tumours.与实验动物及人类肿瘤相关的肿瘤抗原的性质与表达
Ann Clin Biochem. 1976 Sep;13(5):488-94. doi: 10.1177/000456327601300146.
6
[Serum level of tissue polypeptide antigen and its mechanism of elevation in patients with benign liver diseases and hepatocellular carcinoma].[良性肝病和肝细胞癌患者血清组织多肽抗原水平及其升高机制]
Nihon Shokakibyo Gakkai Zasshi. 1984 Mar;81(3):927.
7
Distribution of five antigens in hepatocellular carcinoma.五种抗原在肝细胞癌中的分布。
Lab Invest. 1979 Aug;41(2):101-5.
8
The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.血清组织多肽抗原浓度在肝细胞癌诊断中的价值。
Cancer. 1986 Jul 1;58(1):127-30. doi: 10.1002/1097-0142(19860701)58:1<127::aid-cncr2820580122>3.0.co;2-w.
9
[Pathological and serological investigation on early primary hepatocellular carcinoma and its liver disease background (author's transl)].早期原发性肝细胞癌及其肝脏疾病背景的病理与血清学研究（作者译）
Zhonghua Zhong Liu Za Zhi. 1979;1(1):13-19.
10
Simultaneous assays of cancer-associated antigens in various neoplastic disorders.多种肿瘤性疾病中癌症相关抗原的同步检测。
Cancer. 1976 Dec;38(6):2287-95. doi: 10.1002/1097-0142(197612)38:6<2287::aid-cncr2820380616>3.0.co;2-2.
引用本文的文献
1
The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer.碳水化合物抗原19-9作为食管癌肿瘤标志物的作用。
Br J Cancer. 1989 Aug;60(2):249-51. doi: 10.1038/bjc.1989.263.
本文引用的文献
1
Gastrointestinal cancer-associated antigen in immunoperoxidase assay.免疫过氧化物酶测定中的胃肠道癌相关抗原
Cancer Res. 1982 Nov;42(11):4820-3.
2
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.上消化道疾病患者中新型肿瘤标志物CA 19-9与甲胎蛋白和癌胚抗原的比较
J Clin Pathol. 1984 Feb;37(2):218-22. doi: 10.1136/jcp.37.2.218.
3
Alpha-fetoprotein in primary liver cancer and other diseases.原发性肝癌及其他疾病中的甲胎蛋白。
Gut. 1974 Oct;15(10):814-21. doi: 10.1136/gut.15.10.814.
4
The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.血清组织多肽抗原浓度在肝细胞癌诊断中的价值。
Cancer. 1986 Jul 1;58(1):127-30. doi: 10.1002/1097-0142(19860701)58:1<127::aid-cncr2820580122>3.0.co;2-w.
5
Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.恶性和非恶性疾病患者血清中一种单克隆抗体定义抗原（CA19-9）的测定。与癌胚抗原的比较。
Cancer. 1985 Jul 15;56(2):277-83. doi: 10.1002/1097-0142(19850715)56:2<277::aid-cncr2820560213>3.0.co;2-m.
Zotero 插件